Skip to content

AngioDynamics ANGO Ratios & Valuation

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
Profitability
Gross margin54.3%-0.3pp54.6%+0.4pp54.1%+0.2pp53.9%-0.4pp54.4%+1.6pp
Operating margin-11.3%-0.7pp-10.6%+1.9pp-12.5%+1.2pp-13.7%+3.5pp-17.2%+66.1pp
Net margin-10%-1.0pp-9%+1.7pp-10.7%+0.9pp-11.6%+3.0pp-14.6%+63.8pp
EBITDA margin-3.9%-1.1pp-2.8%+1.3pp-4.1%+0.7pp-4.8%+2.9pp-7.7%+65.8pp
Returns
Return on equity-17.5%-2.2pp-15.3%+1.8pp-17.1%+0.4pp-17.5%+3.0pp-20.5%+56.0pp
Return on assets-11.5%-1.6pp-9.9%+1.6pp-11.5%-0.1pp-11.4%+2.2pp-13.6%+43.2pp
Return on invested capital-24.4%-1.2pp-23.2%+2.4pp-25.6%+3.7pp-29.3%+3.9pp-33.2%+65.7pp
Efficiency
Asset turnover1.1×+0.1×1.1×0.0×1.1×+0.1×+0.1×0.9×+0.2×
Inventory turnover2.4×+0.2×2.1×0.0×2.2×0.0×2.2×+0.1×2.1×+0.1×
Liquidity
Current ratio2.4×+0.1×2.2×-0.1×2.3×+0.1×2.2×0.0×2.2×+0.2×
Quick ratio1.5×+0.1×1.3×-0.1×1.4×0.0×1.4×0.0×1.4×+0.2×
Cash ratio0.6×0.0×0.6×0.0×0.6×-0.2×0.7×+0.2×0.6×0.0×
Leverage
Debt-to-equity0.0×0.0×0.0×0.1×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$4.17-1.8%$4.24-2.3%$4.34-3.0%$4.48-1.6%$4.55-0.3%
Valuation
Market capitalization$564.42M+38.7%$510.88M+22.5%$416.9M+5.7%$394.29M+4.9%$375.93M+33.5%
Enterprise value$534.51M+48.0%$477.53M+24.3%$384.23M+10.2%$348.55M+3.0%$338.34M+45.6%
Price / sales1.8×+0.4×1.7×+0.3×1.4×0.0×1.3×0.0×1.3×+0.3×
Price / book3.3×+1.0×2.9×+0.6×2.3×+0.2×2.2×+0.1×+0.5×
EV / sales1.7×+0.5×1.6×+0.3×1.3×+0.1×1.2×0.0×1.2×+0.4×
Earnings yield-5.6%+2.8pp-5.4%+2.3pp-7.7%+0.9pp-8.6%+2.4pp-11%+68.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are AngioDynamics's profit margins?
AngioDynamics (ANGO) runs a 54.3% gross margin and a -11.3% operating margin, with a -10.0% net margin.
Where do AngioDynamics's ratios come from?
Every ratio is computed from AngioDynamics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.